> Almac has doubled its drug product development capacity with a new non-GMP formulation facility and two analytical laboratories at its U.K. headquarters. News
> Chinese CRO Tigermed is reaching out to Oracle ($ORCL) to manage the wealth of data generated through its clinical trials, using its Oracle Health Sciences InForm platform to track and verify results. More
> Icon ($ICLR) is teaming up with Cerner, an electronic health records specialist, planning to use the company's software to manage study data. Article
> Drug delivery contractor OctoPlus has inked a Master Service Agreement with Sanofi ($SNY) that covers the development of undisclosed new formulations. Story
> Lonza is looking to double its antibody drug conjugate manufacturing in an effort to reverse the fortunes of one of its Swiss plants. Item